Evaluate the Safety and Efficacy of Bremelanotide in Women With Female Sexual Arousal Disorder (FSAD)
Public ClinicalTrials.gov record NCT00425256. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This 8 week at home study is designed to explore efficacy endpoints and evaluate the safety of intranasal Bremelanotide in women with Female Sexual Arousal Disorder. Efficacy will be assessed vs. a parallel placebo group.
Study identification
- NCT ID
- NCT00425256
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- May 2007 (Actual)
- Completion
- May 2007 (Actual)
- Last update posted
- Feb 23, 2011
2006 – 2007
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Affiliated Research Center | Huntsville | Alabama | — | — |
| Quality of Life Medical & Research Center, LLC | Tucson | Arizona | — | — |
| University of California, Department of Family and Preventative Medicine | La Jolla | California | — | — |
| Downtown Women's Health Care | Denver | Colorado | — | — |
| Coastal Connecticut Research | New London | Connecticut | — | — |
| South Florida Medical Research | Aventura | Florida | — | — |
| Clinical Study Center | Fort Myers | Florida | — | — |
| Center For Marital and Sexual Health of South Florida | West Palm Beach | Florida | — | — |
| Northeast Indiana Research | Fort Wayne | Indiana | — | — |
| Center for Sexual Medicine at Sheppard Pratt | Baltimore | Maryland | — | — |
| Advanced Biomedical Research, Inc | Hackensack | New Jersey | — | — |
| The Center for Female Sexuality | Purchase | New York | — | — |
| Wake Research Associates, LLC | Raleigh | North Carolina | — | — |
| Lyndhurst Gynecologic Associates | Winston-Salem | North Carolina | — | — |
| The Ohio State University | Columbus | Ohio | — | — |
| Medford Women's Clinic, LLP | Medford | Oregon | — | — |
| Clinical Trials Research Services, LLC | Pittsburgh | Pennsylvania | — | — |
| Advanced Clinical Therapies, Inc. | West Reading | Pennsylvania | — | — |
| Accelovance | Houston | Texas | — | — |
| Women's Clinical Research Center | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00425256, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 23, 2011 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00425256 live on ClinicalTrials.gov.